News
REGISTER HERE
We’re delighted to have colleagues from across industry and academia joining us at our upcoming User Group Meeting in June. We look forward to this special opportunity to engage with Cresset software users and non-users to discuss the challenges in the field of computational chemistry, as well as the latest innovations at the forefront of drug discovery after having a short break in the User Group schedule due to the pandemic.
Over the years we’ve seen excellent discussions and collaborations resulting from the unique opportunity that getting together in-person for the annual meeting provides. This year we will meet in Brussels and look forward to welcoming you with our programme of scientific talks, hands-on workshops, networking receptions and opportunities for one-on-one discussions throughout the meeting.
We’re delighted to be welcoming guest industry speakers from Eli Lilly and Company, AC Immune, Globachem, The Open ForceField, AbbVie, Charm Therapeutics, and Evariste, all highlighting the use of Cresset computational methods and workflow solutions for their small molecule discovery targets.
Hear from our Chief Scientific Officer, Mark Mackey, on the cutting-edge science and technology developments from the latest research in the Cresset labs. “Past Cresset UGMs have been excellent places to meet other Cresset users, talk to the Cresset scientists and developers building the next generation of software tools, and hear some fascinating talks. I hope that you can join us in Brussels for a couple of days of great science!”.
Whether you are new to Cresset solutions or have worked with us from the start, the meeting will share insights and solutions for those wanting to efficiently design the best molecules.
Don’t miss this opportunity to be part of these important discussions, as we learn from each other and work together to advance small molecule discovery.
Join us in Brussels! Register now: https://www.cresset-group.com/about/events/cresset-user-group-meeting-2024/
We explore how the new Spark linker databases comprehensively include known and commercial degrader linkers as supported by experimental data, ...
To support research and development of Targeted Protein Degradation (TPD) therapeutics, four new linker databases have been released for Spark, ...
We showcase some examples within a drug discovery context where the pyFlare environment has been further expanded with advanced data ...